Payment overview · 2025
General Payments
$1,748.78
101 reported records · 17 companies
Healthcare provider profile · identity verified
Najmuddin Kutbuddin Karimjee, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HOUSTON, TX · NPI 1285660241
Verified facts
What the public records show
CMS Open Payments records show Najmuddin Kutbuddin Karimjee, M.D. received $1,748.78 in general payments during 2025 across 101 reported records.
ABBVIE INC. accounted for 36.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 29 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Airsupra, Creon, Farxiga, Kerendia, Linzess, Qulipta, Synthroid, Ubrelvy, Veozah, Vraylar.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 308 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported QULIPTA as an associated drug or biological on 298617 records involving 58957 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Qulipta by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 177 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported UBRELVY as an associated drug or biological on 299803 records involving 61203 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Ubrelvy by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Vraylar by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Prolia by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 209 claims for Myrbetriq by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Veozah as an associated drug or biological on 82795 records involving 35863 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Veozah by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AIRSUPRA as an associated drug or biological on 165148 records involving 56069 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Airsupra by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 71 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 1073 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 106 claims for Symbicort by this doctor in 2024.
Bayer Healthcare Pharmaceuticals Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Kerendia as an associated drug or biological on 138674 records involving 48458 distinct recipient NPIs. Public Medicare Part D data also shows 47 claims for Kerendia by this doctor in 2024.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 154 claims for Entresto by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 642 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 168 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $638.20 | 36.5% | 50 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $258.29 | 14.8% | 13 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $159.71 | 9.1% | 6 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $153.81 | 8.8% | 3 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $100.57 | 5.8% | 5 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $53.85 | 3.1% | 3 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $52.95 | 3.0% | 3 | 2025 |
| Mannkind Corporation | Unresolved — no canonical attribution shown | $52.31 | 3.0% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $46.62 | 2.7% | 3 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $44.78 | 2.6% | 2 | 2025 |
| Almatica Pharma LLC | Unresolved — no canonical attribution shown | $37.34 | 2.1% | 2 | 2025 |
| Validus Pharmaceuticals LLC | Unresolved — no canonical attribution shown | $32.39 | 1.9% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $27.47 | 1.6% | 2 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $24.05 | 1.4% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.40 | 1.3% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $22.40 | 1.3% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $20.64 | 1.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,748.78 | 101 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $258.29 | 13 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $240.24 | 20 | 2025 |
Source payment records
|
|||||
| SYNTHROID Normalized: synthroid |
Drug | ABBVIE INC. | $211.11 | 14 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $166.95 | 15 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $137.84 | 2 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $122.87 | 4 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $115.54 | 9 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $100.57 | 5 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $94.58 | 2 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $83.72 | 7 | 2025 |
Source payment records
|
|||||
| CREON Normalized: creon |
Drug | ABBVIE INC. | $79.72 | 6 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $52.95 | 3 | 2025 |
Source payment records
|
|||||
| AFREZZA Normalized: afrezza |
Drug | Mannkind Corporation | $52.31 | 3 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $40.07 | 2 | 2025 |
Source payment records
|
|||||
| LOREEV XR Normalized: loreev xr |
Drug | Almatica Pharma LLC | $37.34 | 2 | 2025 |
Source payment records
|
|||||
| RALDESY Normalized: raldesy |
Drug | Validus Pharmaceuticals LLC | $32.39 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $29.94 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $29.94 | 2 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $27.47 | 2 | 2025 |
Source payment records
|
|||||
| Symbravo Normalized: symbravo |
Drug | Axsome Therapeutics, Inc. | $25.61 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $24.05 | 1 | 2025 |
Source payment records
|
|||||
| CARDIOMEMS Normalized: cardiomems |
Device | Abbott Laboratories | $23.40 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $22.40 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $20.64 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $19.17 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $17.50 | 1 | 2025 |
Source payment records
|
|||||
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $16.68 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.97 | 1 | 2025 |
Source payment records
|
|||||
| KEVEYIS Normalized: keveyis |
Drug | Xeris Pharmaceuticals, Inc. | $13.78 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AIRSUPRA airsupra |
2025 | Airsupra | 2024 | 16 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| CREON creon |
2025 | Creon | 2024 | 15 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 1073 | exact normalized | Medicare Part D |
| Kerendia kerendia |
2025 | Kerendia | 2024 | 47 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 308 | exact normalized | Medicare Part D |
| QULIPTA qulipta |
2025 | Qulipta | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| SYNTHROID synthroid |
2025 | Synthroid | 2024 | 177 | exact normalized | Medicare Part D |
| UBRELVY ubrelvy |
2025 | Ubrelvy | 2024 | 15 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Veozah veozah |
2025 | Veozah | 2024 | 26 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| VRAYLAR vraylar |
2025 | Vraylar | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
35 | 12 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
308 | 115 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | QULIPTA open payments reported associated product |
CMS Open Payments — General Payments 298617 supporting records · 58957 recipient NPIs · example record 1201352530 |
Qulipta · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
177 | 58 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | UBRELVY open payments reported associated product |
CMS Open Payments — General Payments 299803 supporting records · 61203 recipient NPIs · example record 1201352530 |
Ubrelvy · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
31 | 19 |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
209 | 59 |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Veozah open payments reported associated product |
CMS Open Payments — General Payments 82795 supporting records · 35863 recipient NPIs · example record 1238560678 |
Veozah · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | AIRSUPRA open payments reported associated product |
CMS Open Payments — General Payments 165148 supporting records · 56069 recipient NPIs · example record 1206131344 |
Airsupra · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
71 | 26 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
1073 | 358 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
106 | 43 |
| Bayer Healthcare Pharmaceuticals Inc. Exact reporting entity; no affiliate inference |
2025 | Kerendia open payments reported associated product |
CMS Open Payments — General Payments 138674 supporting records · 48458 recipient NPIs · example record 1225434663 |
Kerendia · 2024 Exact normalized brand match · 1 Part D row |
47 | 17 |
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
154 | 57 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
642 | 205 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
168 | 167 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 5551 | 1908 |
| Amlodipine Besylate | Amlodipine Besylate | 3936 | 1343 |
| Levothyroxine Sodium | Levothyroxine Sodium | 3399 | 1009 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 3260 | 1152 |
| Lisinopril | Lisinopril | 2729 | 951 |
| Metformin Hcl | Metformin Hcl | 2658 | 938 |
| Gabapentin | Gabapentin | 2634 | 961 |
| Pantoprazole Sodium | Pantoprazole Sodium | 2341 | 853 |
| Losartan Potassium | Losartan Potassium | 2068 | 759 |
| Montelukast Sodium | Montelukast Sodium | 1749 | 620 |
| Furosemide | Furosemide | 1727 | 679 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 1724 | 751 |
| Metoprolol Succinate | Metoprolol Succinate | 1704 | 623 |
| Omeprazole | Omeprazole | 1682 | 590 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1560 | 558 |
| Fluticasone Propionate | Fluticasone Propionate | 1432 | 676 |
| Prednisone | Prednisone | 1399 | 949 |
| Azithromycin | Azithromycin | 1269 | 1000 |
| Carvedilol | Carvedilol | 1251 | 446 |
| Tramadol Hcl | Tramadol Hcl | 1218 | 342 |
| Mounjaro | Tirzepatide | 1199 | 271 |
| Trazodone Hcl | Trazodone Hcl | 1188 | 424 |
| Ozempic | Semaglutide | 1180 | 315 |
| Hydrochlorothiazide | Hydrochlorothiazide | 1147 | 441 |
| Clopidogrel | Clopidogrel Bisulfate | 1106 | 405 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 1098 | 377 |
| Tizanidine Hcl | Tizanidine Hcl | 1086 | 554 |
| Celecoxib | Celecoxib | 1082 | 438 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 1078 | 350 |
| Farxiga | Dapagliflozin Propanediol | 1073 | 358 |
| Duloxetine Hcl | Duloxetine Hcl | 1053 | 386 |
| Meloxicam | Meloxicam | 1027 | 517 |
| Alprazolam | Alprazolam | 1012 | 211 |
| Metformin Hcl Er | Metformin Hcl | 970 | 361 |
| Metoprolol Tartrate | Metoprolol Tartrate | 952 | 337 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 902 | 380 |
| Famotidine | Famotidine | 868 | 332 |
| Glimepiride | Glimepiride | 837 | 308 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 822 | 272 |
| Pregabalin | Pregabalin | 807 | 232 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 803 | 299 |
| Potassium Chloride | Potassium Chloride | 784 | 320 |
| Pioglitazone Hcl | Pioglitazone Hcl | 750 | 257 |
| Zolpidem Tartrate | Zolpidem Tartrate | 743 | 183 |
| Alendronate Sodium | Alendronate Sodium | 731 | 244 |
| Fluoxetine Hcl | Fluoxetine Hcl | 704 | 250 |
| Simvastatin | Simvastatin | 679 | 227 |
| Clonazepam | Clonazepam | 666 | 150 |
| Eliquis | Apixaban | 642 | 205 |
| Irbesartan | Irbesartan | 636 | 226 |
| Sertraline Hcl | Sertraline Hcl | 629 | 213 |
| Quetiapine Fumarate | Quetiapine Fumarate | 613 | 218 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 580 | 176 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 576 | 267 |
| Ezetimibe | Ezetimibe | 568 | 206 |
| Pravastatin Sodium | Pravastatin Sodium | 564 | 194 |
| Lorazepam | Lorazepam | 551 | 152 |
| Nifedipine Er | Nifedipine | 548 | 202 |
| Diclofenac Sodium | Diclofenac Sodium | 534 | 284 |
| Glipizide | Glipizide | 532 | 194 |
| Escitalopram Oxalate | Escitalopram Oxalate | 531 | 210 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 525 | 234 |
| Allopurinol | Allopurinol | 520 | 180 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 517 | 434 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 505 | 439 |
| Buspirone Hcl | Buspirone Hcl | 477 | 163 |
| Donepezil Hcl | Donepezil Hcl | 471 | 187 |
| Jardiance | Empagliflozin | 471 | 168 |
| Methylprednisolone | Methylprednisolone | 462 | 408 |
| Temazepam | Temazepam | 460 | 119 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 459 | 359 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 458 | 160 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 458 | 304 |
| Bupropion Xl | Bupropion Hcl | 450 | 164 |
| Fenofibrate | Fenofibrate | 442 | 140 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 439 | 361 |
| Ibuprofen | Ibuprofen | 404 | 253 |
| Spironolactone | Spironolactone | 404 | 145 |
| Mupirocin | Mupirocin | 403 | 301 |
| Aripiprazole | Aripiprazole | 391 | 129 |
| Cefdinir | Cefdinir | 386 | 329 |
| Doxycycline Hyclate | Doxycycline Hyclate | 360 | 303 |
| Finasteride | Finasteride | 360 | 137 |
| Atenolol | Atenolol | 357 | 122 |
| Clonidine Hcl | Clonidine Hcl | 354 | 137 |
| Hydralazine Hcl | Hydralazine Hcl | 344 | 146 |
| Citalopram Hbr | Citalopram Hydrobromide | 337 | 107 |
| Naproxen | Naproxen | 331 | 182 |
| Xarelto | Rivaroxaban | 322 | 104 |
| Fluconazole | Fluconazole | 315 | 221 |
| Linzess | Linaclotide | 308 | 115 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 297 | 100 |
| Ondansetron Odt | Ondansetron | 293 | 170 |
| Amoxicillin | Amoxicillin | 287 | 244 |
| Meclizine Hcl | Meclizine Hcl | 285 | 167 |
| Levofloxacin | Levofloxacin | 284 | 234 |
| Januvia | Sitagliptin Phosphate | 282 | 93 |
| Nebivolol Hcl | Nebivolol Hcl | 280 | 97 |
| Ropinirole Hcl | Ropinirole Hcl | 275 | 97 |
| Ondansetron Hcl | Ondansetron Hcl | 269 | 148 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 266 | 81 |
| Baclofen | Baclofen | 254 | 113 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 252 | 94 |
| Nystatin | Nystatin | 252 | 137 |
| Amitriptyline Hcl | Amitriptyline Hcl | 250 | 96 |
| Cephalexin | Cephalexin | 243 | 208 |
| Valacyclovir | Valacyclovir Hcl | 238 | 129 |
| Paroxetine Hcl | Paroxetine Hcl | 237 | 87 |
| Dicyclomine Hcl | Dicyclomine Hcl | 231 | 132 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 229 | 73 |
| Oxybutynin Chloride | Oxybutynin Chloride | 228 | 87 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 228 | 89 |
| Fenofibrate | Fenofibrate Nanocrystallized | 220 | 92 |
| Memantine Hcl | Memantine Hcl | 220 | 81 |
| Mirtazapine | Mirtazapine | 217 | 90 |
| Glipizide Er | Glipizide | 214 | 69 |
| Myrbetriq | Mirabegron | 209 | 59 |
| Olanzapine | Olanzapine | 208 | 68 |
| Topiramate | Topiramate | 208 | 79 |
| Azelastine Hcl | Azelastine Hcl | 207 | 104 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 206 | 83 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 202 | 57 |
| Methocarbamol | Methocarbamol | 198 | 94 |
| Bumetanide | Bumetanide | 195 | 72 |
| Propranolol Hcl | Propranolol Hcl | 195 | 70 |
| Levetiracetam | Levetiracetam | 190 | 71 |
| Verapamil Er | Verapamil Hcl | 189 | 59 |
| Diazepam | Diazepam | 179 | 52 |
| Synthroid | Levothyroxine Sodium | 177 | 58 |
| Rybelsus | Semaglutide | 172 | 62 |
| Testosterone Cypionate | Testosterone Cypionate | 171 | 70 |
| Paxlovid | Nirmatrelvir/Ritonavir | 168 | 167 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 168 | 61 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 166 | 90 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 162 | 58 |
| Enalapril Maleate | Enalapril Maleate | 160 | 49 |
| Entresto | Sacubitril/Valsartan | 154 | 57 |
| Metronidazole | Metronidazole | 153 | 132 |
| Bupropion Hcl Sr | Bupropion Hcl | 152 | 64 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 149 | 112 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 149 | 43 |
| Valsartan | Valsartan | 145 | 61 |
| Lactulose | Lactulose | 143 | 70 |
| Clindamycin Hcl | Clindamycin Hcl | 142 | 123 |
| Estradiol | Estradiol | 139 | 57 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 139 | 55 |
| Tradjenta | Linagliptin | 139 | 44 |
| Promethazine Hcl | Promethazine Hcl | 138 | 45 |
| Trulicity | Dulaglutide | 138 | 52 |
| Tresiba Flextouch U-100 | Insulin Degludec | 136 | 50 |
| Chlorthalidone | Chlorthalidone | 133 | 45 |
| Sumatriptan Succinate | Sumatriptan Succinate | 132 | 52 |
| Risperidone | Risperidone | 130 | 50 |
| Sucralfate | Sucralfate | 130 | 71 |
| Sildenafil Citrate | Sildenafil Citrate | 127 | 39 |
| Amiodarone Hcl | Amiodarone Hcl | 126 | 50 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 126 | 36 |
| Doxazosin Mesylate | Doxazosin Mesylate | 120 | 38 |
| Ramipril | Ramipril | 120 | 41 |
| Terbinafine Hcl | Terbinafine Hcl | 120 | 74 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 116 | 23 |
| Ketoconazole | Ketoconazole | 115 | 54 |
| Levemir Flexpen | Insulin Detemir | 115 | 50 |
| Metolazone | Metolazone | 114 | 47 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 110 | 41 |
| Ranolazine Er | Ranolazine | 110 | 37 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 110 | 37 |
| Symbicort | Budesonide/Formoterol Fumarate | 106 | 43 |
| Divalproex Sodium | Divalproex Sodium | 105 | 37 |
| Lidocaine | Lidocaine | 102 | 45 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 100 | 31 |
| Nitroglycerin | Nitroglycerin | 99 | 65 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 99 | 97 |
| Tresiba Flextouch U-200 | Insulin Degludec | 98 | 33 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 98 | 38 |
| Repaglinide | Repaglinide | 97 | 41 |
| Hydrocortisone | Hydrocortisone | 96 | 54 |
| Solifenacin Succinate | Solifenacin Succinate | 96 | 41 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 92 | 30 |
| Clotrimazole | Clotrimazole | 91 | 62 |
| Colchicine | Colchicine | 90 | 49 |
| Divalproex Sodium Er | Divalproex Sodium | 89 | 27 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 88 | 29 |
| Breo Ellipta | Fluticasone/Vilanterol | 88 | 31 |
| Lovastatin | Lovastatin | 88 | 35 |
| Digoxin | Digoxin | 87 | 27 |
| Methimazole | Methimazole | 87 | 35 |
| Methotrexate | Methotrexate Sodium | 87 | 30 |
| Novolog Flexpen | Insulin Aspart | 87 | 33 |
| Latanoprost | Latanoprost | 86 | 34 |
| Lamotrigine | Lamotrigine | 85 | 25 |
| Rizatriptan | Rizatriptan Benzoate | 79 | 27 |
| Ventolin Hfa | Albuterol Sulfate | 78 | 38 |
| Benazepril Hcl | Benazepril Hcl | 76 | 21 |
| Cefuroxime | Cefuroxime Axetil | 75 | 55 |
| Clobetasol Propionate | Clobetasol Propionate | 75 | 52 |
| Humalog Kwikpen U-100 | Insulin Lispro | 75 | 39 |
| Cilostazol | Cilostazol | 73 | 28 |
| Dapagliflozin | Dapagliflozin Propanediol | 73 | 60 |
| Pioglitazone-Metformin | Pioglitazone Hcl/Metformin Hcl | 73 | 25 |
| Telmisartan | Telmisartan | 72 | 26 |
| Vascepa | Icosapent Ethyl | 72 | 27 |
| Brilinta | Ticagrelor | 71 | 26 |
| Gemtesa | Vibegron | 71 | 30 |
| Megestrol Acetate | Megestrol Acetate | 71 | 28 |
| Varenicline Tartrate | Varenicline Tartrate | 71 | 27 |
| Propranolol Hcl Er | Propranolol Hcl | 69 | 24 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 69 | 26 |
| Acyclovir | Acyclovir | 68 | 36 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 68 | 36 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 67 | 28 |
| Ofloxacin | Ofloxacin | 67 | 60 |
| Breyna | Budesonide/Formoterol Fumarate | 66 | 31 |
| Metoclopramide Hcl | Metoclopramide Hcl | 66 | 33 |
| Torsemide | Torsemide | 66 | 25 |
| Desloratadine | Desloratadine | 65 | 24 |
| Gemfibrozil | Gemfibrozil | 64 | 20 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 64 | 32 |
| Liothyronine Sodium | Liothyronine Sodium | 63 | 17 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 63 | 37 |
| Etodolac | Etodolac | 62 | 36 |
| Terazosin Hcl | Terazosin Hcl | 62 | 17 |
| Eszopiclone | Eszopiclone | 60 | 16 |
| Warfarin Sodium | Warfarin Sodium | 59 | 15 |
| Dexlansoprazole Dr | Dexlansoprazole | 58 | 24 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 58 | 14 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 57 | 25 |
| Diclofenac Potassium | Diclofenac Potassium | 56 | 29 |
| Levemir | Insulin Detemir | 55 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 54 | 22 |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 54 | 15 |
| Alcohol Pads | Alcohol Antiseptic Pads | 53 | 17 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 53 | 14 |
| Ibandronate Sodium | Ibandronate Sodium | 52 | 20 |
| Primidone | Primidone | 52 | 18 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 52 | 16 |
| Venlafaxine Hcl | Venlafaxine Hcl | 52 | 17 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 50 | 28 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 50 | 17 |
| Folic Acid | Folic Acid | 50 | 19 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | 18 |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 50 | 31 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 49 | suppressed |
| Carbamazepine | Carbamazepine | 49 | 18 |
| Midodrine Hcl | Midodrine Hcl | 49 | 23 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 49 | 15 |
| Kerendia | Finerenone | 47 | 17 |
| Doxepin Hcl | Doxepin Hcl | 46 | 18 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 46 | 26 |
| Oxcarbazepine | Oxcarbazepine | 45 | 21 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 44 | 14 |
| Lansoprazole | Lansoprazole | 44 | 16 |
| Anastrozole | Anastrozole | 43 | 16 |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 43 | 18 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 42 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 41 | 16 |
| Repatha Sureclick | Evolocumab | 41 | 14 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 41 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 40 | 12 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 40 | 18 |
| Fenofibrate | Fenofibrate,micronized | 40 | 16 |
| Prazosin Hcl | Prazosin Hcl | 40 | 16 |
| Betamethasone Valerate | Betamethasone Valerate | 39 | 25 |
| Spiriva Respimat | Tiotropium Bromide | 39 | 14 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 38 | 14 |
| Dutasteride | Dutasteride | 38 | 15 |
| Glyburide | Glyburide | 38 | 15 |
| Mometasone Furoate | Mometasone Furoate | 37 | 20 |
| Repatha Syringe | Evolocumab | 37 | 12 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 36 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 36 | 15 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 36 | 22 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 36 | 16 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 36 | suppressed |
| Tadalafil | Tadalafil | 36 | 13 |
| Armour Thyroid | Thyroid,pork | 35 | 12 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 35 | 24 |
| Clonidine | Clonidine | 35 | 12 |
| Loperamide | Loperamide Hcl | 35 | 26 |
| Premarin | Estrogens, Conjugated | 35 | 17 |
| Flecainide Acetate | Flecainide Acetate | 34 | 11 |
| Glyxambi | Empagliflozin/Linagliptin | 34 | suppressed |
| Sotalol | Sotalol Hcl | 34 | 11 |
| Nystop | Nystatin | 33 | 19 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 32 | 11 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 32 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 32 | suppressed |
| Klor-Con M20 | Potassium Chloride | 32 | 15 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 32 | 29 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 32 | 11 |
| Roflumilast | Roflumilast | 32 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 31 | 15 |
| Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 31 | 27 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 31 | 15 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 31 | 19 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 31 | 13 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 31 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 31 | 28 |
| Prolia | Denosumab | 31 | 19 |
| Constulose | Lactulose | 28 | 21 |
| Droplet Pen Needle | Pen Needle, Diabetic | 28 | 17 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 28 | 13 |
| Verapamil Sr | Verapamil Hcl | 28 | 13 |
| Clarithromycin | Clarithromycin | 27 | 26 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 27 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 27 | suppressed |
| Ibu | Ibuprofen | 27 | 20 |
| Nabumetone | Nabumetone | 27 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 26 | 13 |
| Moxifloxacin | Moxifloxacin Hcl | 26 | 18 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 26 | suppressed |
| Veozah | Fezolinetant | 26 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 25 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 25 | 17 |
| Modafinil | Modafinil | 25 | suppressed |
| Rexulti | Brexpiprazole | 25 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Febuxostat | Febuxostat | 24 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 24 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 24 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 24 | suppressed |
| Carbamazepine Er | Carbamazepine | 23 | suppressed |
| Carbinoxamine Maleate | Carbinoxamine Maleate | 23 | 14 |
| Humalog Kwikpen U-200 | Insulin Lispro | 23 | suppressed |
| Vraylar | Cariprazine Hcl | 23 | suppressed |
| Calcitriol | Calcitriol | 22 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 22 | 20 |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 22 | 22 |
| Ciclopirox | Ciclopirox | 21 | 13 |
| Comfort Ez Insulin Syringe | Syringe And Needle,insulin,1ml | 21 | suppressed |
| Eplerenone | Eplerenone | 21 | suppressed |
| Invokana | Canagliflozin | 21 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 21 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 20 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 20 | 11 |
| Erythromycin | Erythromycin Base | 20 | 19 |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 20 | suppressed |
| Acetic Acid | Acetic Acid | 19 | 17 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 19 | 12 |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Cromolyn Sodium | Cromolyn Sodium | 19 | 14 |
| Dilantin | Phenytoin Sodium Extended | 19 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Permethrin | Permethrin | 19 | 17 |
| Prasugrel Hcl | Prasugrel Hcl | 19 | suppressed |
| Ursodiol | Ursodiol | 19 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 18 | suppressed |
| Epinephrine | Epinephrine | 18 | 15 |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 18 | 14 |
| Naltrexone Hcl | Naltrexone Hcl | 18 | suppressed |
| Restasis | Cyclosporine | 18 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 18 | 15 |
| Sure Comfort | Syringe And Needle,insulin,1ml | 18 | suppressed |
| True Comfort Alcohol Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 17 | 12 |
| Insulin Aspart Flexpen | Insulin Aspart | 17 | suppressed |
| Klor-Con 10 | Potassium Chloride | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Pentoxifylline | Pentoxifylline | 17 | suppressed |
| Travoprost | Travoprost | 17 | suppressed |
| Airsupra | Albuterol Sulfate/Budesonide | 16 | suppressed |
| Amiloride-Hydrochlorothiazide | Amiloride/Hydrochlorothiazide | 16 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 16 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 16 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Indapamide | Indapamide | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Movantik | Naloxegol Oxalate | 16 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 16 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 16 | 12 |
| Acarbose | Acarbose | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Progesterone | Progesterone, Micronized | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 15 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 15 | suppressed |
| Ubrelvy | Ubrogepant | 15 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Budesonide Er | Budesonide | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 14 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 14 | suppressed |
| Enulose | Lactulose | 14 | 13 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 14 | suppressed |
| Leflunomide | Leflunomide | 14 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 14 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 14 | suppressed |
| Tobramycin | Tobramycin | 14 | 14 |
| Adderall | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Altavera | Levonorgestrel/Ethin.Estradiol | 13 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 13 | suppressed |
| Niacin Er | Niacin | 13 | suppressed |
| Nortrel | Norethindrone-Ethin. Estradiol | 13 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 13 | suppressed |
| Trulance | Plecanatide | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Dupixent Syringe | Dupilumab | 12 | suppressed |
| Minoxidil | Minoxidil | 12 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 12 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 12 | 12 |
| Pen Needle | Pen Needle, Diabetic | 12 | 11 |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 12 | 12 |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Valproic Acid | Valproic Acid | 12 | suppressed |
| Wegovy | Semaglutide | 12 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 11 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 11 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Calcipotriene | Calcipotriene | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Dovato | Dolutegravir Sodium/Lamivudine | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 11 | suppressed |
| Indomethacin | Indomethacin | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Mesalamine | Mesalamine | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Pimozide | Pimozide | 11 | suppressed |
| Qulipta | Atogepant | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Tri-Sprintec | Norgestimate-Ethinyl Estradiol | 11 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,748.78 · 101 records | ABBVIE INC. | AFREZZA, AIRSUPRA, Auvelity, BREZTRI, CAPLYTA, CARDIOMEMS, CREON, Cologuard Collection Kit, FARXIGA, GVOKE HYPOPEN, INGREZZA, KEVEYIS, KRYSTEXXA, Kerendia, LEQVIO, LINZESS, LOREEV XR, NURTEC ODT, OTEZLA, QULIPTA, RALDESY, REPATHA, SYNTHROID, Symbravo, The Cologuard Plus Collection Kit, UBRELVY, VOQUEZNA, VRAYLAR, Veozah | 18 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Airsupra play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error